JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB28

Anti-p53 抗体 [PAb 1801]

Anti-p53 antibody [PAb 1801]

4

(13 Reviews)

|

(63 Publications)

Mouse Monoclonal P53 antibody. Suitable for ELISA, WB and reacts with Human samples. Cited in 63 publications.

別名を表示する

P53, TP53, Cellular tumor antigen p53, Antigen NY-CO-13, Phosphoprotein p53, Tumor suppressor p53

5 Images
ELISA - Anti-p53 antibody [PAb 1801] (AB28)
  • ELISA

Unknown

ELISA - Anti-p53 antibody [PAb 1801] (AB28)

Analysis of recombinant p53 protein (ab43615) in MCF7 cells treated with vehicle (VEH)as well as MCF7 cells treated with camptothecin (CAM) and no material (NO) by sandwich ELISA with the use of anti-53 antibody (ab28) as capture and anti-p53 antibody (ab32389) as detector.

Western blot - Anti-p53 antibody [PAb 1801] (AB28)
  • WB

Lab

Western blot - Anti-p53 antibody [PAb 1801] (AB28)

All Lanes : Anti-p53 antibody [PAb 1801] (ab28) at 5 μg/ml

Lane 1 and 10 : Wild-type HCT116 cell lysate

Lane 2 and 11 : Wild-type HCT116 + irinotecan (10 μM, 24 hours) cell lysate

Lane 3 and 12 : p53 knockout HCT116 cell lysate

Lane 4 and 13 : p53 knockout HCT116 + irinotecan (10 μM, 24 hours) cell lysate

Lane 5 and 14 : A431 cell lysate (positive control)

Lane 6 and 15 : Saos-2 cell lysate (negative control)

Lane 7 and 16 : MEF cell lysate

Lane 8 and 17 : Wild-type HAP1 cell lysate

Lane 9 and 18 : p53 knockout HAP1 cell lysate

Lanes 1-9 : 1% BSA blocking buffer

Lanes 10-18 : 3% Milk blocking buffer

Secondary
Goat Anti-Mouse IgG H&L (HRP) at 1/5000 dilution

We recommend using 3% milk as the blocking agent for western blot.

All lanes:

Western blot - Anti-p53 antibody [PAb 1801] (ab28)

Predicted band size: 43 kDa

true

Western blot - Anti-p53 antibody [PAb 1801] (AB28)
  • WB

Unknown

Western blot - Anti-p53 antibody [PAb 1801] (AB28)

The image shows a Western blot for ab28, testing the threshold detection of the p53 antibody. The lanes are as follows :

Lane 1 - 20ug of A549 lysate, lane 2 - 10ug of A549 lysate, lane 3 - 5ug of A549 lysate, lane 4 - 2.5ug of A549 lysate, lane 5 - 1.5ug of A549 lysate.

This picture was submitted as part of the review by Craig Carson.

All lanes:

Western blot - Anti-p53 antibody [PAb 1801] (ab28)

Predicted band size: 43 kDa

false

Western blot - Anti-p53 antibody [PAb 1801] (AB28)
  • WB

Lab

Western blot - Anti-p53 antibody [PAb 1801] (AB28)

Lanes 1-9 : Merged (red and green) signal.

ab28 was shown to specifically react with p53 in wild-type HAP1 and HCT116 cells treated with irinotecan. No band was observed in p53 knockout HAP1 or HCT116 cells. Wild-type and p53 knockout samples, positive and negative controls were subjected to SDS-PAGE. ab28 and ab181602 (loading control to GAPDH) were diluted 5 μg/mL and 1/10,000 respectively and incubated overnight at 4°C. Blots were developed with goat anti-rabbit IgG (H + L) and goat anti-mouse IgG (H + L) secondary antibodies at 1/10,000 dilution for 1 h at room temperature before imaging.

All lanes:

Western blot - Anti-p53 antibody [PAb 1801] (ab28) at 5 µg/mL

Lane 1:

Wild-type HCT116 cell lysate at 30 µg

Lane 2:

Wild-type HCT116 + irinotecan (10 μM, 24 hours) cell lysate at 30 µg

Lane 3:

p53 knockout HCT116 cell lysate at 30 µg

Lane 4:

p53 knockout HCT116 + irinotecan (10 μM, 24 hours) cell lysate at 30 µg

Lane 5:

A431 cell lysate (positive control) at 20 µg

Lane 6:

Saos-2 cell lysate (negative control) at 20 µg

Lane 7:

MEF cell lysate at 20 µg

Lane 8:

Wild-type HAP1 cell lysate at 20 µg

Lane 9:

p53 knockout HAP1 cell lysate at 20 µg

Predicted band size: 43 kDa

false

Western blot - Anti-p53 antibody [PAb 1801] (AB28)
  • WB

Ap

Western blot - Anti-p53 antibody [PAb 1801] (AB28)

This blot was produced using a 10% Bis-tris gel under the MOPS buffer system. The gel was run at 200V for 50 minutes before being transferred onto a Nitrocellulose membrane at 30V for 70 minutes. The membrane was then blocked for an hour using 3% Milk before being incubated with ab28 overnight at 4°C. Antibody binding was detected using an anti-mouse antibody conjugated to HRP, and visualised using ECL development solution.

We recommend using 3% milk as the blocking agent for Western blot.

All lanes:

Western blot - Anti-p53 antibody [PAb 1801] (ab28) at 5 µg/mL

All lanes:

MDA-MB-231 (Human breast adenocarcinoma cell line) Whole Cell Lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Mouse IgG H&L (HRP) preadsorbed (<a href='/products/secondary-antibodies/goat-mouse-igg-h-l-hrp-preadsorbed-ab97040'>ab97040</a>) at 1/10000 dilution

Predicted band size: 43 kDa

Observed band size: 53 kDa,60 kDa

true

Exposure time: 20min

Key facts

宿主種

Mouse

クローン性

Monoclonal

クローン番号

PAb 1801

アイソタイプ

IgG1

軽鎖のタイプ

kappa

キャリアフリー

No

交差種

Human

アプリケーション

ELISA, WB

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

エピトープ

aa 46-55 of human p53

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "ELISA" : {"fullname" : "ELISA", "shortname":"ELISA"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "ELISA-species-checked": "testedAndGuaranteed", "ELISA-species-dilution-info": "", "ELISA-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "5 µg/mL", "WB-species-notes": "<p>We recommend using 3% milk as the blocking agent for Western blot.</p>" } } }

製品の詳細

This monoclonal p53 antibody has been knockout validated in Western blot. The expected band for p53 was observed in HCT116 cells treated with irinotecan and the band was not seen in TP53 knockout HCT116 cell lysate.

We recommend using ab1101 or ab154036, alternative mouse monoclonal antibodies, to detect human p53 by IHC, ICC/IF or flow cytometry since they perform better in these applications.

Want a custom formulation?
This antibody clone is manufactured by Abcam. If you require a custom buffer formulation or conjugation for your experiments, please contact orders@abcam.com

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification
バッファー組成
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS
出荷温度
Blue Ice
短期保存温度
+4°C
長期保存温度
-20°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

The protein p53 also known as TP53 or tumor protein p53 has a molecular weight of approximately 53 kDa. It acts as a transcription factor and plays a major role in cell cycle regulation apoptosis and maintaining genomic stability. This protein mainly expresses in the nucleus of cells and acts as a critical regulator of cellular responses to stress signals including DNA damage. Scientists commonly use p53 antibodies in various assays like western blot and p53 immunofluorescence to detect and study its expression and functional status in cells.
Biological function summary

P53 functions to control cell division and apoptosis serving as a guardian of the genome by preventing mutation accumulation. It does not form part of a larger complex under normal conditions but interacts with various other molecules to execute its functions. p53 can activate or suppress the transcription of numerous genes involved in cell cycle arrest DNA repair and programmed cell death allowing it to halt the progression of damaged cells and trigger repair mechanisms or eliminate those that cannot be repaired.

Pathways

P53 acts within several key biological pathways such as the p53 signaling pathway and the intrinsic apoptotic pathway. Its activity involves interaction with proteins like MDM2 which regulates p53 through ubiquitin-mediated degradation and ATM kinase which phosphorylates p53 in response to DNA damage. These interactions ensure appropriate cellular responses during stress and are vital for maintaining homeostasis.

P53 mutation or inactivation is often associated with the development of cancer given its role in controlling cell division and preventing tumor formation. Specifically its dysfunction has been linked to cancers such as breast cancer and lung cancer. Additionally p53 can interact with other mutant proteins like Ras compounding mutations that contribute to tumor progression and aggressive cancer phenotypes. Understanding these interactions and the status of p53 can be important in developing targeted cancer therapies.

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:

ターゲットの情報

Multifunctional transcription factor that induces cell cycle arrest, DNA repair or apoptosis upon binding to its target DNA sequence (PubMed : 11025664, PubMed : 12524540, PubMed : 12810724, PubMed : 15186775, PubMed : 15340061, PubMed : 17317671, PubMed : 17349958, PubMed : 19556538, PubMed : 20673990, PubMed : 20959462, PubMed : 22726440, PubMed : 24051492, PubMed : 24652652, PubMed : 35618207, PubMed : 36634798, PubMed : 38653238, PubMed : 9840937). Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type (PubMed : 11025664, PubMed : 12524540, PubMed : 12810724, PubMed : 15186775, PubMed : 15340061, PubMed : 17189187, PubMed : 17317671, PubMed : 17349958, PubMed : 19556538, PubMed : 20673990, PubMed : 20959462, PubMed : 22726440, PubMed : 24051492, PubMed : 24652652, PubMed : 38653238, PubMed : 9840937). Negatively regulates cell division by controlling expression of a set of genes required for this process (PubMed : 11025664, PubMed : 12524540, PubMed : 12810724, PubMed : 15186775, PubMed : 15340061, PubMed : 17317671, PubMed : 17349958, PubMed : 19556538, PubMed : 20673990, PubMed : 20959462, PubMed : 22726440, PubMed : 24051492, PubMed : 24652652, PubMed : 9840937). One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression (PubMed : 12524540, PubMed : 17189187). Its pro-apoptotic activity is activated via its interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 (PubMed : 12524540). However, this activity is inhibited when the interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 is displaced by PPP1R13L/iASPP (PubMed : 12524540). In cooperation with mitochondrial PPIF is involved in activating oxidative stress-induced necrosis; the function is largely independent of transcription. Induces the transcription of long intergenic non-coding RNA p21 (lincRNA-p21) and lincRNA-Mkln1. LincRNA-p21 participates in TP53-dependent transcriptional repression leading to apoptosis and seems to have an effect on cell-cycle regulation. Implicated in Notch signaling cross-over. Prevents CDK7 kinase activity when associated to CAK complex in response to DNA damage, thus stopping cell cycle progression. Isoform 2 enhances the transactivation activity of isoform 1 from some but not all TP53-inducible promoters. Isoform 4 suppresses transactivation activity and impairs growth suppression mediated by isoform 1. Isoform 7 inhibits isoform 1-mediated apoptosis. Regulates the circadian clock by repressing CLOCK-BMAL1-mediated transcriptional activation of PER2 (PubMed : 24051492).
See full target information TP53

文献 (63)

Recent publications for all applications. Explore the full list and refine your search

Cell reports. Medicine 6:101918 PubMed39809263

2025

Single-molecule systems for the detection and monitoring of plasma-circulating nucleosomes and oncoproteins in diffuse midline glioma.

Applications

Unspecified application

Species

Unspecified reactive species

Nir Erez,Noa Furth,Vadim Fedyuk,Jack Wadden,Rayan Aittaleb,Tiffany Adam,Kallen Schwark,Michael Niculcea,Madeline Miclea,Rajen Mody,Andrea Franson,Hemant A Parmar,Mohannad Ibrahim,Benison Lau,Augustine Eze,Niku Nourmohammadi,Iris Fried,Javad Nazarian,Guy Ron,Sriram Venneti,Carl Koschmann,Efrat Shema

Scientific reports 13:9674 PubMed37316553

2023

Breviscapine regulates the proliferation, migration, invasion, and apoptosis of colorectal cancer cells via the PI3K/AKT pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Pengfei Niu,Feng Liu,Fuming Lei,Jisheng Peng,Yanzhao Wang,Jun Zhao,Zhaoya Gao,Qingkun Gao,Jin Gu

Scientific reports 11:6939 PubMed33767253

2021

SPINK7 expression changes accompanied by HER2, P53 and RB1 can be relevant in predicting oral squamous cell carcinoma at a molecular level.

Applications

Unspecified application

Species

Unspecified reactive species

Gina Pennacchiotti,Fabio Valdés-Gutiérrez,Wilfredo Alejandro González-Arriagada,Héctor Federico Montes,Judith Maria Roxana Parra,Valeria Andrea Guida,Silvina Esther Gómez,Martin Eduardo Guerrero-Gimenez,Juan Manuel Fernandez-Muñoz,Felipe Carlos Martin Zoppino,Rubén Walter Carón,Marcelo Eduardo Ezquer,Ricardo Fernández-Ramires,Flavia Alejandra Bruna

Frontiers in immunology 11:599771 PubMed33628204

2021

Identification of Neuronal Pentraxins as Synaptic Binding Partners of C1q and the Involvement of NP1 in Synaptic Pruning in Adult Mice.

Applications

Unspecified application

Species

Unspecified reactive species

Réka Á Kovács,Henrietta Vadászi,Éva Bulyáki,György Török,Vilmos Tóth,Dominik Mátyás,Judit Kun,Éva Hunyadi-Gulyás,Flóra Zsófia Fedor,Ádám Csincsi,Katalin Medzihradszky,László Homolya,Gábor Juhász,Katalin A Kékesi,Mihály Józsi,Balázs A Györffy,József Kardos

International journal of medical sciences 18:1753-1759 PubMed33746592

2021

Carboxypeptidase A4 negatively correlates with p53 expression and regulates the stemness of breast cancer cells.

Applications

Unspecified application

Species

Unspecified reactive species

Yipeng Wang,Yibin Xie,Yanan Niu,Peng Song,Ye Liu,Joseph Burnett,Zhihua Yang,Duxin Sun,Yuliang Ran,Yang Li,Lichao Sun

JBMR plus 4:e10376 PubMed32803108

2020

Nox4 Expression Is Not Required for OVX-Induced Osteoblast Senescence and Bone Loss in Mice.

Applications

Unspecified application

Species

Unspecified reactive species

Jin-Ran Chen,Oxana P Lazarenko,Haijun Zhao,Umesh D Wankhade,Kim Pedersen,James Watt,Martin J J Ronis

eLife 9: PubMed32223892

2020

exploits host ATM kinase for survival advantage through SecA2 secretome.

Applications

Unspecified application

Species

Unspecified reactive species

Savita Lochab,Yogendra Singh,Sagar Sengupta,Vinay Kumar Nandicoori

Journal of the American Heart Association 9:e014008 PubMed31928155

2020

Detection of a High Ratio of Soluble to Membrane-Bound LOX-1 in Aspirated Coronary Thrombi From Patients With ST-Segment-Elevation Myocardial Infarction.

Applications

Unspecified application

Species

Unspecified reactive species

An-Sheng Lee,Yu-Chen Wang,Shih-Sheng Chang,Ping-Hang Lo,Chia-Ming Chang,Jonathan Lu,Alan R Burns,Chu-Huang Chen,Akemi Kakino,Tatsuya Sawamura,Kuan-Cheng Chang

Current protocols in stem cell biology 52:e102 PubMed31883435

2019

Efficient Modulation of TP53 Expression in Human Induced Pluripotent Stem Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Constanze Uhlmann,Lisa-Maria Kuhn,Julia Tigges,Ellen Fritsche,Ulf Dietrich Kahlert

Oncogene 39:1041-1048 PubMed31582835

2019

EZH2 targeting reduces medulloblastoma growth through epigenetic reactivation of the BAI1/p53 tumor suppressor pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Hanwen Zhang,Dan Zhu,Zhaobin Zhang,Stefan Kaluz,Bing Yu,Narra S Devi,Jeffrey J Olson,Erwin G Van Meir
View all publications

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com